Advertisement

Index by author

June 01, 2003; Volume 31,Issue 6

A

  1. Andersson, Tommy B.

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

B

  1. Bacon, Jim

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  2. Bakhtiar, Ray

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  3. Bao, Yongping

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  4. Baune, Bruno

    1. IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION
      Denis Projean, Bruno Baune, Robert Farinotti, Jean-Pierre Flinois, Philippe Beaune, Anne-Marie Taburet and Julie Ducharme
      Drug Metabolism and Disposition June 2003, 31 (6) 748-754; DOI: https://doi.org/10.1124/dmd.31.6.748

  5. Beaune, Philippe

    1. IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION
      Denis Projean, Bruno Baune, Robert Farinotti, Jean-Pierre Flinois, Philippe Beaune, Anne-Marie Taburet and Julie Ducharme
      Drug Metabolism and Disposition June 2003, 31 (6) 748-754; DOI: https://doi.org/10.1124/dmd.31.6.748

  6. Benet, Leslie Z.

    1. COVALENT BINDING OF 2-PHENYLPROPIONYL-S-ACYL-COA THIOESTER TO TISSUE PROTEINS IN VITRO
      Chunze Li, Mobolaji O. Olurinde, Laura M. Hodges, Mark P. Grillo and Leslie Z. Benet
      Drug Metabolism and Disposition June 2003, 31 (6) 727-730; DOI: https://doi.org/10.1124/dmd.31.6.727

  7. Bonnert, Roger V.

    1. NMR IDENTIFICATION OF AN S-LINKED GLUCURONIDE OF A TRIAZOLE THIONE FORMED IN VITRO
      Iain J. Martin, Richard J. Lewis, Roger V. Bonnert, Peter Cage and Graeme C. Moody
      Drug Metabolism and Disposition June 2003, 31 (6) 694-696; DOI: https://doi.org/10.1124/dmd.31.6.694

  8. Boobis, Alan R.

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

C

  1. Cage, Peter

    1. NMR IDENTIFICATION OF AN S-LINKED GLUCURONIDE OF A TRIAZOLE THIONE FORMED IN VITRO
      Iain J. Martin, Richard J. Lewis, Roger V. Bonnert, Peter Cage and Graeme C. Moody
      Drug Metabolism and Disposition June 2003, 31 (6) 694-696; DOI: https://doi.org/10.1124/dmd.31.6.694

  2. Chen, Chuan

    1. HEPATOBILIARY EXCRETION OF ACETAMINOPHEN GLUTATHIONE CONJUGATE AND ITS DERIVATIVES IN TRANSPORT-DEFICIENT (TR-) HYPERBILIRUBINEMIC RATS
      Chuan Chen, Gayle E. Hennig and José E. Manautou
      Drug Metabolism and Disposition June 2003, 31 (6) 798-804; DOI: https://doi.org/10.1124/dmd.31.6.798

  3. Chen, Xiaoyan

    1. IDENTIFICATION OF THE METABOLITES OF 9-NITRO-20(S)-CAMPTOTHECIN IN RATS
      Ke Li, Xiaoyan Chen, Dafang Zhong and Yan Li
      Drug Metabolism and Disposition June 2003, 31 (6) 792-797; DOI: https://doi.org/10.1124/dmd.31.6.792

  4. Chicchi, Gary G.

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  5. Chiu, Shuet-Hing L.

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  6. Chung, Hye Chin

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  7. Ciccotto, Suzanne L.

    1. INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3
      Sui Wang, Dylan P. Hartley, Suzanne L. Ciccotto, Stella H. Vincent, Ronald B. Franklin and Mi-Sook Kim
      Drug Metabolism and Disposition June 2003, 31 (6) 773-775; DOI: https://doi.org/10.1124/dmd.31.6.773

  8. Cole, S.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  9. Comby, P.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

D

  1. Dean, Brian J.

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  2. Deng, Mei

    1. HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATIN
      Danyelle M. Townsend, Jarrod A. Marto, Mei Deng, Timothy J. Macdonald and Marie H. Hanigan
      Drug Metabolism and Disposition June 2003, 31 (6) 705-713; DOI: https://doi.org/10.1124/dmd.31.6.705

  3. DeVane, C. Lindsay

    1. INVOLVEMENT OF CYP3A4, CYP2C8, AND CYP2D6 IN THE METABOLISM OF (R)- AND (S)-METHADONE IN VITRO
      Jun-Sheng Wang and C. Lindsay DeVane
      Drug Metabolism and Disposition June 2003, 31 (6) 742-747; DOI: https://doi.org/10.1124/dmd.31.6.742

  4. Ducharme, Julie

    1. IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION
      Denis Projean, Bruno Baune, Robert Farinotti, Jean-Pierre Flinois, Philippe Beaune, Anne-Marie Taburet and Julie Ducharme
      Drug Metabolism and Disposition June 2003, 31 (6) 748-754; DOI: https://doi.org/10.1124/dmd.31.6.748

  5. Duffel, Michael W.

    1. ENANTIOSELECTIVITY OF HUMAN HYDROXYSTEROID SULFOTRANSFERASE ST2A3 WITH NAPHTHYL-1-ETHANOLS
      Jonathan J. Sheng and Michael W. Duffel
      Drug Metabolism and Disposition June 2003, 31 (6) 697-700; DOI: https://doi.org/10.1124/dmd.31.6.697

E

  1. Edwards, Robert J.

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

  2. Elfarra, Adnan A.

    1. DISTINCT TISSUE DISTRIBUTION OF METABOLITES OF THE NOVEL GLUTATHIONE-ACTIVATED THIOPURINE PRODRUGS CIS-6-(2-ACETYLVINYLTHIO)PURINE AND TRANS-6-(2-ACETYLVINYLTHIO)GUANINE AND 6-THIOGUANINE IN THE MOUSE
      Sjofn Gunnarsdottir and Adnan A. Elfarra
      Drug Metabolism and Disposition June 2003, 31 (6) 718-726; DOI: https://doi.org/10.1124/dmd.31.6.718

  3. Eriksson, Thomas

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

F

  1. Farinotti, Robert

    1. IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION
      Denis Projean, Bruno Baune, Robert Farinotti, Jean-Pierre Flinois, Philippe Beaune, Anne-Marie Taburet and Julie Ducharme
      Drug Metabolism and Disposition June 2003, 31 (6) 748-754; DOI: https://doi.org/10.1124/dmd.31.6.748

  2. Flinois, Jean-Pierre

    1. IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION
      Denis Projean, Bruno Baune, Robert Farinotti, Jean-Pierre Flinois, Philippe Beaune, Anne-Marie Taburet and Julie Ducharme
      Drug Metabolism and Disposition June 2003, 31 (6) 748-754; DOI: https://doi.org/10.1124/dmd.31.6.748

  3. Forsell, Patrik

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  4. Franklin, Ronald B.

    1. INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3
      Sui Wang, Dylan P. Hartley, Suzanne L. Ciccotto, Stella H. Vincent, Ronald B. Franklin and Mi-Sook Kim
      Drug Metabolism and Disposition June 2003, 31 (6) 773-775; DOI: https://doi.org/10.1124/dmd.31.6.773

  5. Fujiki, Yuto

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

G

  1. Gerk, Phillip M.

    1. BASOLATERAL ACTIVE UPTAKE OF NITROFURANTOIN IN THE CIT3 CELL CULTURE MODEL OF LACTATION
      Phillip M. Gerk, Jeffrey A. Moscow and Patrick J. McNamara
      Drug Metabolism and Disposition June 2003, 31 (6) 691-693; DOI: https://doi.org/10.1124/dmd.31.6.691

  2. Gibson, D.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  3. Grillo, Mark P.

    1. COVALENT BINDING OF 2-PHENYLPROPIONYL-S-ACYL-COA THIOESTER TO TISSUE PROTEINS IN VITRO
      Chunze Li, Mobolaji O. Olurinde, Laura M. Hodges, Mark P. Grillo and Leslie Z. Benet
      Drug Metabolism and Disposition June 2003, 31 (6) 727-730; DOI: https://doi.org/10.1124/dmd.31.6.727

  4. Gunnarsdottir, Sjofn

    1. DISTINCT TISSUE DISTRIBUTION OF METABOLITES OF THE NOVEL GLUTATHIONE-ACTIVATED THIOPURINE PRODRUGS CIS-6-(2-ACETYLVINYLTHIO)PURINE AND TRANS-6-(2-ACETYLVINYLTHIO)GUANINE AND 6-THIOGUANINE IN THE MOUSE
      Sjofn Gunnarsdottir and Adnan A. Elfarra
      Drug Metabolism and Disposition June 2003, 31 (6) 718-726; DOI: https://doi.org/10.1124/dmd.31.6.718

H

  1. Hanigan, Marie H.

    1. HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATIN
      Danyelle M. Townsend, Jarrod A. Marto, Mei Deng, Timothy J. Macdonald and Marie H. Hanigan
      Drug Metabolism and Disposition June 2003, 31 (6) 705-713; DOI: https://doi.org/10.1124/dmd.31.6.705

  2. Hargreaves, Richard

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  3. Hartley, Dylan P.

    1. INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3
      Sui Wang, Dylan P. Hartley, Suzanne L. Ciccotto, Stella H. Vincent, Ronald B. Franklin and Mi-Sook Kim
      Drug Metabolism and Disposition June 2003, 31 (6) 773-775; DOI: https://doi.org/10.1124/dmd.31.6.773

  4. Hennig, Gayle E.

    1. HEPATOBILIARY EXCRETION OF ACETAMINOPHEN GLUTATHIONE CONJUGATE AND ITS DERIVATIVES IN TRANSPORT-DEFICIENT (TR-) HYPERBILIRUBINEMIC RATS
      Chuan Chen, Gayle E. Hennig and José E. Manautou
      Drug Metabolism and Disposition June 2003, 31 (6) 798-804; DOI: https://doi.org/10.1124/dmd.31.6.798

  5. Hodges, Laura M.

    1. COVALENT BINDING OF 2-PHENYLPROPIONYL-S-ACYL-COA THIOESTER TO TISSUE PROTEINS IN VITRO
      Chunze Li, Mobolaji O. Olurinde, Laura M. Hodges, Mark P. Grillo and Leslie Z. Benet
      Drug Metabolism and Disposition June 2003, 31 (6) 727-730; DOI: https://doi.org/10.1124/dmd.31.6.727

  6. Holst, Birgit

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  7. Hora, Donald F.

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  8. Huskey, Su-Er W.

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

I

  1. Ingelman-Sundberg, Magnus

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

  2. Inoue, Masaki

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

J

  1. Jezequel, S. G.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  2. Johansson, Anna

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

  3. Johansson, Inger

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

K

  1. Keohane, Carolann

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  2. Kim, Eun Jung

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  3. Kim, Mi-Sook

    1. INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3
      Sui Wang, Dylan P. Hartley, Suzanne L. Ciccotto, Stella H. Vincent, Ronald B. Franklin and Mi-Sook Kim
      Drug Metabolism and Disposition June 2003, 31 (6) 773-775; DOI: https://doi.org/10.1124/dmd.31.6.773

  4. Kim, Sang Geon

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  5. Kim, So Hee

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  6. Knutson, Lars

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  7. Kroon, Paul A.

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  8. Kuroiwa, Yukio

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

  9. Kyo, Satoru

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

L

  1. Lee, Ae Kyung

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  2. Lee, Duk Chul

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  3. Lee, Inchul

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  4. Lee, Myung Gull

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  5. Lennernas, Hans

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  6. Lewis, Richard J.

    1. NMR IDENTIFICATION OF AN S-LINKED GLUCURONIDE OF A TRIAZOLE THIONE FORMED IN VITRO
      Iain J. Martin, Richard J. Lewis, Roger V. Bonnert, Peter Cage and Graeme C. Moody
      Drug Metabolism and Disposition June 2003, 31 (6) 694-696; DOI: https://doi.org/10.1124/dmd.31.6.694

  7. Li, Chunze

    1. COVALENT BINDING OF 2-PHENYLPROPIONYL-S-ACYL-COA THIOESTER TO TISSUE PROTEINS IN VITRO
      Chunze Li, Mobolaji O. Olurinde, Laura M. Hodges, Mark P. Grillo and Leslie Z. Benet
      Drug Metabolism and Disposition June 2003, 31 (6) 727-730; DOI: https://doi.org/10.1124/dmd.31.6.727

  8. Li, Ke

    1. IDENTIFICATION OF THE METABOLITES OF 9-NITRO-20(S)-CAMPTOTHECIN IN RATS
      Ke Li, Xiaoyan Chen, Dafang Zhong and Yan Li
      Drug Metabolism and Disposition June 2003, 31 (6) 792-797; DOI: https://doi.org/10.1124/dmd.31.6.792

  9. Li, Yan

    1. IDENTIFICATION OF THE METABOLITES OF 9-NITRO-20(S)-CAMPTOTHECIN IN RATS
      Ke Li, Xiaoyan Chen, Dafang Zhong and Yan Li
      Drug Metabolism and Disposition June 2003, 31 (6) 792-797; DOI: https://doi.org/10.1124/dmd.31.6.792

M

  1. Macdonald, Timothy J.

    1. HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATIN
      Danyelle M. Townsend, Jarrod A. Marto, Mei Deng, Timothy J. Macdonald and Marie H. Hanigan
      Drug Metabolism and Disposition June 2003, 31 (6) 705-713; DOI: https://doi.org/10.1124/dmd.31.6.705

  2. Malmebo, Sarah

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

  3. Manautou, José E.

    1. HEPATOBILIARY EXCRETION OF ACETAMINOPHEN GLUTATHIONE CONJUGATE AND ITS DERIVATIVES IN TRANSPORT-DEFICIENT (TR-) HYPERBILIRUBINEMIC RATS
      Chuan Chen, Gayle E. Hennig and José E. Manautou
      Drug Metabolism and Disposition June 2003, 31 (6) 798-804; DOI: https://doi.org/10.1124/dmd.31.6.798

  4. Martin, Iain J.

    1. NMR IDENTIFICATION OF AN S-LINKED GLUCURONIDE OF A TRIAZOLE THIONE FORMED IN VITRO
      Iain J. Martin, Richard J. Lewis, Roger V. Bonnert, Peter Cage and Graeme C. Moody
      Drug Metabolism and Disposition June 2003, 31 (6) 694-696; DOI: https://doi.org/10.1124/dmd.31.6.694

  5. Marto, Jarrod A.

    1. HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATIN
      Danyelle M. Townsend, Jarrod A. Marto, Mei Deng, Timothy J. Macdonald and Marie H. Hanigan
      Drug Metabolism and Disposition June 2003, 31 (6) 705-713; DOI: https://doi.org/10.1124/dmd.31.6.705

  6. McNamara, Patrick J.

    1. BASOLATERAL ACTIVE UPTAKE OF NITROFURANTOIN IN THE CIT3 CELL CULTURE MODEL OF LACTATION
      Phillip M. Gerk, Jeffrey A. Moscow and Patrick J. McNamara
      Drug Metabolism and Disposition June 2003, 31 (6) 691-693; DOI: https://doi.org/10.1124/dmd.31.6.691

  7. Mellon, Fred A.

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  8. Moody, Graeme C.

    1. NMR IDENTIFICATION OF AN S-LINKED GLUCURONIDE OF A TRIAZOLE THIONE FORMED IN VITRO
      Iain J. Martin, Richard J. Lewis, Roger V. Bonnert, Peter Cage and Graeme C. Moody
      Drug Metabolism and Disposition June 2003, 31 (6) 694-696; DOI: https://doi.org/10.1124/dmd.31.6.694

  9. Moon, Young Jin

    1. EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS
      Young Jin Moon, Ae Kyung Lee, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Duk Chul Lee, Inchul Lee, Sang Geon Kim and Myung Gull Lee
      Drug Metabolism and Disposition June 2003, 31 (6) 776-784; DOI: https://doi.org/10.1124/dmd.31.6.776

  10. Moscow, Jeffrey A.

    1. BASOLATERAL ACTIVE UPTAKE OF NITROFURANTOIN IN THE CIT3 CELL CULTURE MODEL OF LACTATION
      Phillip M. Gerk, Jeffrey A. Moscow and Patrick J. McNamara
      Drug Metabolism and Disposition June 2003, 31 (6) 691-693; DOI: https://doi.org/10.1124/dmd.31.6.691

N

  1. Nakajima, Miki

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

  2. Nedderman, A. N. R.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  3. Noda, Kumiko

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

O

  1. O'Leary, Karen A.

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  2. Ohkuni, Hisashi

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

  3. Ohtsuka, Hiroki

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

  4. Olurinde, Mobolaji O.

    1. COVALENT BINDING OF 2-PHENYLPROPIONYL-S-ACYL-COA THIOESTER TO TISSUE PROTEINS IN VITRO
      Chunze Li, Mobolaji O. Olurinde, Laura M. Hodges, Mark P. Grillo and Leslie Z. Benet
      Drug Metabolism and Disposition June 2003, 31 (6) 727-730; DOI: https://doi.org/10.1124/dmd.31.6.727

  5. Otter, Charlotta

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

P

  1. Perjesi, Pal

    1. QUINOL-BASED METABOLIC CYCLE FOR ESTROGENS IN RAT LIVER MICROSOMES
      Laszlo Prokai, Katalin Prokai-Tatrai, Pal Perjesi, Alevtina D. Zharikova and James W. Simpkins
      Drug Metabolism and Disposition June 2003, 31 (6) 701-704; DOI: https://doi.org/10.1124/dmd.31.6.701

  2. Petri, Niclas

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  3. Plumb, Geoff W.

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  4. Projean, Denis

    1. IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION
      Denis Projean, Bruno Baune, Robert Farinotti, Jean-Pierre Flinois, Philippe Beaune, Anne-Marie Taburet and Julie Ducharme
      Drug Metabolism and Disposition June 2003, 31 (6) 748-754; DOI: https://doi.org/10.1124/dmd.31.6.748

  5. Prokai, Laszlo

    1. QUINOL-BASED METABOLIC CYCLE FOR ESTROGENS IN RAT LIVER MICROSOMES
      Laszlo Prokai, Katalin Prokai-Tatrai, Pal Perjesi, Alevtina D. Zharikova and James W. Simpkins
      Drug Metabolism and Disposition June 2003, 31 (6) 701-704; DOI: https://doi.org/10.1124/dmd.31.6.701

  6. Prokai-Tatrai, Katalin

    1. QUINOL-BASED METABOLIC CYCLE FOR ESTROGENS IN RAT LIVER MICROSOMES
      Laszlo Prokai, Katalin Prokai-Tatrai, Pal Perjesi, Alevtina D. Zharikova and James W. Simpkins
      Drug Metabolism and Disposition June 2003, 31 (6) 701-704; DOI: https://doi.org/10.1124/dmd.31.6.701

R

  1. Ramamoorthy, Yamini

    1. INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2003, 31 (6) 768-772; DOI: https://doi.org/10.1124/dmd.31.6.768

  2. Ring, Barbara J.

    1. THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES
      Matthew G. Soars, Barbara J. Ring and Steven A. Wrighton
      Drug Metabolism and Disposition June 2003, 31 (6) 762-767; DOI: https://doi.org/10.1124/dmd.31.6.762

  3. Roffey, S. J.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  4. Rycroft, Wayne

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

S

  1. Sanchez, Rosa I.

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  2. Sellers, Edward M.

    1. INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2003, 31 (6) 768-772; DOI: https://doi.org/10.1124/dmd.31.6.768

  3. Sheng, Jonathan J.

    1. ENANTIOSELECTIVITY OF HUMAN HYDROXYSTEROID SULFOTRANSFERASE ST2A3 WITH NAPHTHYL-1-ETHANOLS
      Jonathan J. Sheng and Michael W. Duffel
      Drug Metabolism and Disposition June 2003, 31 (6) 697-700; DOI: https://doi.org/10.1124/dmd.31.6.697

  4. Siegmund, W.

    1. INFLUENCE OF PROPIVERINE ON HEPATIC MICROSOMAL CYTOCHROME P450 ENZYMES IN MALE RATS
      R. Walter, C. Ullmann, D. Thümmler and W. Siegmund
      Drug Metabolism and Disposition June 2003, 31 (6) 714-717; DOI: https://doi.org/10.1124/dmd.31.6.714

  5. Simpkins, James W.

    1. QUINOL-BASED METABOLIC CYCLE FOR ESTROGENS IN RAT LIVER MICROSOMES
      Laszlo Prokai, Katalin Prokai-Tatrai, Pal Perjesi, Alevtina D. Zharikova and James W. Simpkins
      Drug Metabolism and Disposition June 2003, 31 (6) 701-704; DOI: https://doi.org/10.1124/dmd.31.6.701

  6. Smith, D. A.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  7. Soars, Matthew G.

    1. THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES
      Matthew G. Soars, Barbara J. Ring and Steven A. Wrighton
      Drug Metabolism and Disposition June 2003, 31 (6) 762-767; DOI: https://doi.org/10.1124/dmd.31.6.762

T

  1. Taburet, Anne-Marie

    1. IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION
      Denis Projean, Bruno Baune, Robert Farinotti, Jean-Pierre Flinois, Philippe Beaune, Anne-Marie Taburet and Julie Ducharme
      Drug Metabolism and Disposition June 2003, 31 (6) 748-754; DOI: https://doi.org/10.1124/dmd.31.6.748

  2. Tannergren, Christer

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  3. Tattersall, F. David

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  4. Thümmler, D.

    1. INFLUENCE OF PROPIVERINE ON HEPATIC MICROSOMAL CYTOCHROME P450 ENZYMES IN MALE RATS
      R. Walter, C. Ullmann, D. Thümmler and W. Siegmund
      Drug Metabolism and Disposition June 2003, 31 (6) 714-717; DOI: https://doi.org/10.1124/dmd.31.6.714

  5. Townsend, Danyelle M.

    1. HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATIN
      Danyelle M. Townsend, Jarrod A. Marto, Mei Deng, Timothy J. Macdonald and Marie H. Hanigan
      Drug Metabolism and Disposition June 2003, 31 (6) 705-713; DOI: https://doi.org/10.1124/dmd.31.6.705

  6. Tyndale, Rachel F.

    1. INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2003, 31 (6) 768-772; DOI: https://doi.org/10.1124/dmd.31.6.768

U

  1. Ullmann, C.

    1. INFLUENCE OF PROPIVERINE ON HEPATIC MICROSOMAL CYTOCHROME P450 ENZYMES IN MALE RATS
      R. Walter, C. Ullmann, D. Thümmler and W. Siegmund
      Drug Metabolism and Disposition June 2003, 31 (6) 714-717; DOI: https://doi.org/10.1124/dmd.31.6.714

V

  1. Vincent, Stella H.

    1. INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3
      Sui Wang, Dylan P. Hartley, Suzanne L. Ciccotto, Stella H. Vincent, Ronald B. Franklin and Mi-Sook Kim
      Drug Metabolism and Disposition June 2003, 31 (6) 773-775; DOI: https://doi.org/10.1124/dmd.31.6.773

W

  1. Walker, D. K.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  2. Walter, R.

    1. INFLUENCE OF PROPIVERINE ON HEPATIC MICROSOMAL CYTOCHROME P450 ENZYMES IN MALE RATS
      R. Walter, C. Ullmann, D. Thümmler and W. Siegmund
      Drug Metabolism and Disposition June 2003, 31 (6) 714-717; DOI: https://doi.org/10.1124/dmd.31.6.714

  3. Wang, Jun-Sheng

    1. INVOLVEMENT OF CYP3A4, CYP2C8, AND CYP2D6 IN THE METABOLISM OF (R)- AND (S)-METHADONE IN VITRO
      Jun-Sheng Wang and C. Lindsay DeVane
      Drug Metabolism and Disposition June 2003, 31 (6) 742-747; DOI: https://doi.org/10.1124/dmd.31.6.742

  4. Wang, Sui

    1. INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3
      Sui Wang, Dylan P. Hartley, Suzanne L. Ciccotto, Stella H. Vincent, Ronald B. Franklin and Mi-Sook Kim
      Drug Metabolism and Disposition June 2003, 31 (6) 773-775; DOI: https://doi.org/10.1124/dmd.31.6.773

  5. Watt, Alan P.

    1. BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS
      Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sanchez, F. David Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, Carolann Keohane, Donald F. Hora and Shuet-Hing L. Chiu
      Drug Metabolism and Disposition June 2003, 31 (6) 785-791; DOI: https://doi.org/10.1124/dmd.31.6.785

  6. Westlind-Johnsson, Anna

    1. COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM
      Anna Westlind-Johnsson, Sarah Malmebo, Anna Johansson, Charlotta Otter, Tommy B. Andersson, Inger Johansson, Robert J. Edwards, Alan R. Boobis and Magnus Ingelman-Sundberg
      Drug Metabolism and Disposition June 2003, 31 (6) 755-761; DOI: https://doi.org/10.1124/dmd.31.6.755

  7. Williamson, Gary

    1. ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
      Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, Jim Bacon, Karen A. O'Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas and Gary Williamson
      Drug Metabolism and Disposition June 2003, 31 (6) 805-813; DOI: https://doi.org/10.1124/dmd.31.6.805

  8. Wood, N.

    1. THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
      S. J. Roffey, S. Cole, P. Comby, D. Gibson, S. G. Jezequel, A. N. R. Nedderman, D. A. Smith, D. K. Walker and N. Wood
      Drug Metabolism and Disposition June 2003, 31 (6) 731-741; DOI: https://doi.org/10.1124/dmd.31.6.731

  9. Wrighton, Steven A.

    1. THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES
      Matthew G. Soars, Barbara J. Ring and Steven A. Wrighton
      Drug Metabolism and Disposition June 2003, 31 (6) 762-767; DOI: https://doi.org/10.1124/dmd.31.6.762

Y

  1. Yokoi, Tsuyoshi

    1. GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION
      Miki Nakajima, Yuto Fujiki, Kumiko Noda, Hiroki Ohtsuka, Hisashi Ohkuni, Satoru Kyo, Masaki Inoue, Yukio Kuroiwa and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2003, 31 (6) 687-690; DOI: https://doi.org/10.1124/dmd.31.6.687

Z

  1. Zhang, Wenjiang

    1. INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale and Edward M. Sellers
      Drug Metabolism and Disposition June 2003, 31 (6) 768-772; DOI: https://doi.org/10.1124/dmd.31.6.768

  2. Zharikova, Alevtina D.

    1. QUINOL-BASED METABOLIC CYCLE FOR ESTROGENS IN RAT LIVER MICROSOMES
      Laszlo Prokai, Katalin Prokai-Tatrai, Pal Perjesi, Alevtina D. Zharikova and James W. Simpkins
      Drug Metabolism and Disposition June 2003, 31 (6) 701-704; DOI: https://doi.org/10.1124/dmd.31.6.701

  3. Zhong, Dafang

    1. IDENTIFICATION OF THE METABOLITES OF 9-NITRO-20(S)-CAMPTOTHECIN IN RATS
      Ke Li, Xiaoyan Chen, Dafang Zhong and Yan Li
      Drug Metabolism and Disposition June 2003, 31 (6) 792-797; DOI: https://doi.org/10.1124/dmd.31.6.792
Back to top

In this issue